TY - JOUR AU - Caggiano, V. AU - Weiss, R. V. AU - Rickert, T. S. AU - Linde-Zwirble, W. T. PY - 2005 DA - 2005// TI - Incidence, cost and mortality of neutropenia hospitalization associated with chemotherapy JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20983 DO - 10.1002/cncr.20983 ID - Caggiano2005 ER - TY - JOUR AU - Smith, T. J. AU - Khatcheressian, J. AU - Lyman, G. H. AU - Ozer, H. AU - Armitage, J. O. AU - Balducci, L. AU - Bennett, C. L. AU - Cantor, S. B. AU - Crawford, J. AU - Cross, S. J. AU - Demetri, G. AU - Desch, C. E. AU - Pizzo, P. A. AU - Schiffer, C. A. AU - Schwartzberg, L. AU - Somerfield, M. R. AU - Somlo, G. AU - Wade, J. C. AU - Wade, J. L. AU - Winn, R. J. AU - Wozniak, A. J. AU - Wolff, A. C. PY - 2006 DA - 2006// TI - 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.4451 DO - 10.1200/JCO.2006.06.4451 ID - Smith2006 ER - TY - JOUR AU - Lyman, G. H. AU - Michels, S. L. AU - Reynolds, M. W. AU - Barron, R. AU - Tomic, K. S. AU - Yu, J. PY - 2010 DA - 2010// TI - Risk of mortality in patients with cancer who experience febrile neutropenia JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25332 DO - 10.1002/cncr.25332 ID - Lyman2010 ER - TY - JOUR AU - Kuderer, N. M. AU - Dale, D. C. AU - Crawford, J. AU - Cosler, L. E. AU - Lyman, G. H. PY - 2006 DA - 2006// TI - Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients JO - Cancer VL - 106 UR - https://doi.org/10.1002/cncr.21847 DO - 10.1002/cncr.21847 ID - Kuderer2006 ER - TY - JOUR AU - Bonadonna, G. AU - Moliterni, A. AU - Zambetti, M. AU - Daidone, M. G. AU - Pilotti, S. AU - Gianni, L. AU - Valagussa, P. PY - 2005 DA - 2005// TI - 30 years’ follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study JO - BMJ VL - 330 UR - https://doi.org/10.1136/bmj.38314.622095.8F DO - 10.1136/bmj.38314.622095.8F ID - Bonadonna2005 ER - TY - JOUR AU - Lyman, G. H. AU - Dale, D. C. AU - Crawford, J. PY - 2003 DA - 2003// TI - Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.05.002 DO - 10.1200/JCO.2003.05.002 ID - Lyman2003 ER - TY - JOUR AU - Kwak, L. W. AU - Halpern, J. AU - Olshen, R. A. AU - Horning, S. J. PY - 1990 DA - 1990// TI - Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis JO - J Clin Oncol VL - 8 ID - Kwak1990 ER - TY - JOUR AU - Hecht, J. R. AU - Pillai, M. AU - Gollard, R. AU - Heim, W. AU - Swan, F. AU - Patel, R. AU - Dreiling, L. AU - Mo, M. AU - Malik, I. PY - 2010 DA - 2010// TI - A randomized placebo-controlled Phase II study evaluating the reduction in neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy JO - Clin Colorectal Cancer VL - 9 UR - https://doi.org/10.3816/CCC.2010.n.013 DO - 10.3816/CCC.2010.n.013 ID - Hecht2010 ER - TY - JOUR AU - Bosly, A. AU - Bron, D. AU - Van Hoof, A. AU - De Bock, R. AU - Berneman, Z. AU - Ferrant, A. AU - Kaufman, L. AU - Dauwe, M. AU - Verhoef, G. PY - 2008 DA - 2008// TI - Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP JO - Ann Hematol VL - 87 UR - https://doi.org/10.1007/s00277-007-0399-y DO - 10.1007/s00277-007-0399-y ID - Bosly2008 ER - TY - JOUR AU - Balducci, L. AU - Al-Halawani, H. AU - Charu, V. AU - Tam, J. AU - Shahin, S. AU - Dreiling, L. AU - Ershler, W. B. PY - 2007 DA - 2007// TI - Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim JO - Oncologist VL - 12 UR - https://doi.org/10.1634/theoncologist.12-12-1416 DO - 10.1634/theoncologist.12-12-1416 ID - Balducci2007 ER - TY - JOUR AU - Romieu, G. AU - Clemens, M. AU - Mahlberg, R. AU - Fargeot, P. AU - Constenla, M. AU - Schütte, M. AU - Easton, V. AU - Skacel, T. AU - Bacon, P. AU - Brugger, W. PY - 2007 DA - 2007// TI - Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial JO - Crit Rev Oncol Hematol VL - 64 UR - https://doi.org/10.1016/j.critrevonc.2006.12.007 DO - 10.1016/j.critrevonc.2006.12.007 ID - Romieu2007 ER - TY - JOUR AU - Smith, T. J. AU - Hillner, B. E. PY - 2012 DA - 2012// TI - A way forward on the medically appropriate use of white cell growth factors JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.9980 DO - 10.1200/JCO.2011.39.9980 ID - Smith2012 ER - TY - JOUR AU - Vogel, C. L. AU - Wojtukiewicz, M. Z. AU - Carroll, R. R. AU - Tjulandin, S. A. AU - Barajas-Figueroa, L. J. AU - Wiens, B. L. AU - Neumann, T. A. AU - Schwartzberg, L. S. PY - 2005 DA - 2005// TI - First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled Phase III study JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.102 DO - 10.1200/JCO.2005.09.102 ID - Vogel2005 ER - TY - JOUR AU - Weycker, D. AU - Malin, J. AU - Barron, R. AU - Edelsberg, J. AU - Kartashov, A. AU - Oster, G. PY - 2012 DA - 2012// TI - Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in cancer chemotherapy patients JO - Am J Clin Oncol VL - 35 UR - https://doi.org/10.1097/COC.0b013e31820dc075 DO - 10.1097/COC.0b013e31820dc075 ID - Weycker2012 ER - TY - JOUR AU - Morrison, V. A. AU - Wong, M. AU - Hershman, D. AU - Campos, L. T. AU - Ding, B. AU - Malin, J. PY - 2007 DA - 2007// TI - Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices JO - J Manag Care Pharm VL - 13 ID - Morrison2007 ER - TY - JOUR AU - Tan, H. AU - Tomic, K. AU - Hurley, D. AU - Daniel, G. AU - Barron, R. AU - Malin, J. PY - 2011 DA - 2011// TI - Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study JO - Curr Med Res Opin VL - 27 UR - https://doi.org/10.1185/03007995.2010.536527 DO - 10.1185/03007995.2010.536527 ID - Tan2011 ER - TY - JOUR AU - Green, M. AU - Koelbl, H. AU - Baselga, J. AU - Galid, A. AU - Guillem, V. AU - Gascon, P. AU - Siena, S. AU - Lalisang, R. I. AU - Samonigg, H. AU - Clemens, M. R. AU - Zani, V. AU - Liang, B. C. AU - Renwick, J. AU - Piccart, M. J. PY - 2003 DA - 2003// TI - A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg019 DO - 10.1093/annonc/mdg019 ID - Green2003 ER - TY - JOUR AU - Holmes, F. AU - O'Shaughnessy, J. AU - Vukelja, S. AU - Jones, S. AU - Shogan, J. AU - Savin, M. AU - Glaspy, J. AU - Moore, M. AU - Meza, L. AU - Wiznitzer, I. AU - Neumann, T. A. AU - Hill, L. R. AU - Liang, B. C. PY - 2002 DA - 2002// TI - Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.20.3.727 DO - 10.1200/JCO.20.3.727 ID - Holmes2002 ER - TY - JOUR AU - Crawford, J. AU - Ozer, H. AU - Stoller, R. AU - Johnson, D. AU - Lyman, G. AU - Tabbara, I. AU - Kris, M. AU - Grous, J. AU - Picozzi, V. AU - Rausch, G. AU - Roy, S. AU - William, G. AU - Anne, Y. AU - Martha, V. AU - Morgan, S. AU - John, G. PY - 1991 DA - 1991// TI - Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer JO - N Engl J Med VL - 325 UR - https://doi.org/10.1056/NEJM199107183250305 DO - 10.1056/NEJM199107183250305 ID - Crawford1991 ER - TY - JOUR AU - Rajan, S. AU - Lyman, G. AU - Stearns, S. AU - Carpenter, W. PY - 2011 DA - 2011// TI - Effect of primary prophylactic granulocyte-colony stimulating factor use on incidence of neutropenia hospitalizations for elderly early-stage breast cancer patients receiving chemotherapy JO - Med Care VL - 49 UR - https://doi.org/10.1097/MLR.0b013e318215c42e DO - 10.1097/MLR.0b013e318215c42e ID - Rajan2011 ER - TY - JOUR AU - Gruschkus, S. K. AU - Lairson, D. AU - Dunn, J. K. AU - Risser, J. AU - Du, X. L. PY - 2010 DA - 2010// TI - Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy JO - J Am Geriatr Soc VL - 58 UR - https://doi.org/10.1111/j.1532-5415.2010.03081.x DO - 10.1111/j.1532-5415.2010.03081.x ID - Gruschkus2010 ER - TY - JOUR AU - Weycker, D. AU - Malin, J. AU - Kim, J. AU - Barron, R. AU - Edelsberg, J. AU - Kartashov, A. AU - Oster, G. PY - 2009 DA - 2009// TI - Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study JO - Clin Ther VL - 31 UR - https://doi.org/10.1016/j.clinthera.2009.05.019 DO - 10.1016/j.clinthera.2009.05.019 ID - Weycker2009 ER - TY - JOUR AU - Weycker, D. AU - Hackett, J. AU - Edelsberg, J. S. AU - Oster, G. AU - Glass, A. G. PY - 2006 DA - 2006// TI - Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? JO - Ann Pharmacother VL - 40 UR - https://doi.org/10.1345/aph.1G516 DO - 10.1345/aph.1G516 ID - Weycker2006 ER - TY - JOUR AU - Scott, S. AU - Chrischilles, E. AU - Link, B. AU - Delgado, D. J. AU - Fridman, M. AU - Stolshek, B. S. PY - 2003 DA - 2003// TI - Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin’s lymphoma treated with chemotherapy JO - J Manag Care Pharm VL - 9 ID - Scott2003 ER - TY - JOUR AU - Rivera, E. AU - Smith, R. E. PY - 2006 DA - 2006// TI - Trends in recommendations for myelosuppressive chemotherapy for the treatment of breast cancer: evolution of the national comprehensive cancer network guidelines and the cooperative group studies JO - Clin Breast Cancer VL - 7 UR - https://doi.org/10.3816/CBC.2006.n.011 DO - 10.3816/CBC.2006.n.011 ID - Rivera2006 ER - TY - JOUR AU - Smith, R. E. PY - 2006 DA - 2006// TI - Trends in recommendations for myelosuppressive chemotherapy for the treatment of solid tumors JO - J Natl Compr Canc Netw VL - 4 ID - Smith2006 ER - TY - CHAP AU - Weycker, D. AU - Barron, R. AU - Edelsberg, J. AU - Kartashov, A. AU - Lyman, G. H. PY - 2012 DA - 2012// TI - Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice BT - Breast Cancer Res Treat ID - Weycker2012 ER - TY - JOUR AU - Chrischilles, E. AU - Delgado, D. J. AU - Stolshek, B. S. AU - Lawless, G. AU - Fridman, M. AU - Carter, W. B. PY - 2002 DA - 2002// TI - Impact of age and colony-stimulating factor use on hospital length of stay for febrile neutropenia in CHOP-treated non-Hodgkin’s Lymphoma JO - Cancer Control VL - 9 ID - Chrischilles2002 ER - TY - STD TI - Public Welfare and the Protection of Human Subjects: 2009, 45 C.F.R. pt. 46.101 ID - ref29 ER - TY - JOUR AU - Groessl, E. J. AU - Kaplan, R. M. AU - Cronan, T. A. PY - 2003 DA - 2003// TI - Quality of well-being in older people with osteoarthritis JO - Arthritis Rheum VL - 49 UR - https://doi.org/10.1002/art.10903 DO - 10.1002/art.10903 ID - Groessl2003 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/14/189/prepub UR - http://www.biomedcentral.com/1472-6963/14/189/prepub ID - ref31 ER -